7h
Dealbreaker on MSNLabcorp Is Buying BioReference Health’s Cancer Testing Business for $192 MillionNearly a year after Labcorp struck a deal for certain diagnostics assets from BioReference Health, the lab-testing giant is ...
LH inks new agreement to acquire BioReference Health's oncology and related clinical testing services businesses.
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Voyager Therapeutics (VYGR – Research Report), ...
The independent laboratory company has entered an agreement to acquire BioReference Health's oncology diagnostic services.
Labcorp has been a great trade, beating the S&P 500 by 6.9%. Its stock price has climbed to $255.01, representing a healthy ...
The stock's rise snapped a seven-day losing streak.
A vehicle crashed into the LabCorp business at 595 Loudon Rd in Newton Plaza II on March 4, causing significant damage to the ...
Labcorp will acquire BioReference Health's oncology diagnostics operations as the lab company works to expand in high-growth ...
This was the stock's sixth consecutive day of losses.
Truist analyst David MacDonald notes Labcorp (LH) announced that the company has reached an agreement to acquire oncology-focused lab testing ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results